Lucas is trained in computational biophysics and protein engineering. He brought Cyrus to sales with over 120 BioPharma companies and collaboration on over 30 discovery stage programs, including work with the majority of top-20 BioPharma firms including Janssen, Genentech, Selecta Bio, and the Broad Institute. At Cyrus Lucas was a co-founder of the OpenFold consortium in Protein AI software with Genentech, Amazon, Outpace and Arzeda. Prior to Cyrus he was a Translational Investigator & Senior Fellow at the Baker lab at UW, developing small-molecule binding proteins and protein design algorithms, and leading efforts to improve the stability and usability of the Rosetta software package. Lucas’ academic work includes a patented computationally designed enzyme, an RNA-dynamics-modeling software toolkit he built from scratch during his PhD, and algorithm optimization for automation of computational protein design. Harvard A.B., Biochemical Sciences (summa cum laude and Goldwater Scholar) and Ph.D., Biophysics; Hertz Fellow.
Lucas Nivon, PhD
CEO and Co-Founder, Cyrus Biotechnology